ArticleAustralian endodontic journal : the journal of the Australian Society of Endodontology Inc2026
Comparison Between Human Amniotic Membrane and Biodentine as A Pulp Capping Agent-An In Vitro Tooth Culture Study.
Article in Australian endodontic journal : the journal of the Australian Society of Endodontology Inc, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The objective of the study was to compare the role of Cryopreserved human amniotic membrane (cHAM) for early pulp biomineralisation in comparison to Biodentine using the tooth culture model. This study was conducted in two stages. The first stage aimed to establish the tooth culture model and assess the viability of pulp cells at 28 and 50 days. In the second stage, pulp capping was performed in the tooth culture model using cHAM and Biodentine. A total of 20 freshly extracted teeth (for orthodontic reasons) were used for pulp capping with either cHAM or Biodentine. The samples were evaluated for biomineralisation at 14 and 28 days using micro-computed tomography (micro-CT) and histological analysis. Morphometric data from micro-CT scans were analysed using the Chi-square test. The viability of pulp cells in the tooth culture model was 66.1% at 28 days and 38.4% at 50 days. Pulp capping with cHAM resulted in a thicker and larger volume of mineralisation at 28 days (720 μm, 0.7 mm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.